• No results found

Relapse Free Survival

A novel gene-pair signature for relapse-free survival prediction in colon cancer

A novel gene-pair signature for relapse-free survival prediction in colon cancer

... cancer, relapse-free survival, gene pair, prognosis Introduction Colorectal cancer (CRC) is one of the most common cancers worldwide, with an estimated ...the relapse rate remains ...

9

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

... A recent meta analysis conducted on a large publicly available set of microarray data from primary breast tumours suggested that breast cancer displayed variable expression of ligands for NK cell receptors. In ...

11

Intratumoral expression of CCR3 in breast cancer is associated with improved relapse-free survival in luminal-like disease

Intratumoral expression of CCR3 in breast cancer is associated with improved relapse-free survival in luminal-like disease

... distant relapse-free survival was also ...on relapse-free survival according to subtype using cases from publicly available datasets, in the whole group (N=3557) and in the ...

9

Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia

Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia

... GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in ...disease-free, relapse-free survival after allogeneic ...

11

Estimating Relapse Free Survival as a Net Probability : Regression Models and Graphical Representation : An Application of a Large Breast Cancer Case Series

Estimating Relapse Free Survival as a Net Probability : Regression Models and Graphical Representation : An Application of a Large Breast Cancer Case Series

... on relapse-free survival. Relapse free is a net survival, since it is interpreted as the relapse- free probability that would be observed if all patients ...

7

Review Article Prognostic value of cervical lymph node metastasis ratio in Asian papillary thyroid carcinoma 5-year relapse-free survival: a meta-analysis

Review Article Prognostic value of cervical lymph node metastasis ratio in Asian papillary thyroid carcinoma 5-year relapse-free survival: a meta-analysis

... disease-free survival ratio and relapse-free survival ratio at different LNR cut- off values were obtained directly from includ- ed ...

10

Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors

Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors

... Introduction Salivary gland tumors are a complex disease entity, encompassing eleven benign and 20 malignant tumors according to the 2017 World Health Organization classification. 1 Malignant salivary gland tumors occur ...

10

Effect of neoadjuvant chemotherapy regimen on relapse free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de escalation of neoadjuvant chemotherapy

Effect of neoadjuvant chemotherapy regimen on relapse free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de escalation of neoadjuvant chemotherapy

... and survival in triple-negative breast cancer has been used for statistical modeling and clinical trial power calculations ...similar survival, but this assumption of NACT regimen equivalence has not been ...

10

Epigenetic homogeneity within colorectal tumors predicts shorter relapse-free and overall survival times for patients with locoregional cancer

Epigenetic homogeneity within colorectal tumors predicts shorter relapse-free and overall survival times for patients with locoregional cancer

... BACKGROUND & AIMS: There are few validated biomarkers that can be used to predict outcomes for patients with colorectal can- cer. Part of the challenge is the genetic and molecular heteroge- neity of colorectal ...

12

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis

... BDNF: Brain-derived neurotrophic factor; BREMS: Bayesian risk estimate for multiple sclerosis; CIS: Clinically isolated syndrome; CNS: Central nervous system; DMT: Disease-modifying therapy; EAE: Experimental autoimmune ...

9

Original Article Time to relapse predicts post-relapse survival in recurrent osteosarcoma: a meta-analysis

Original Article Time to relapse predicts post-relapse survival in recurrent osteosarcoma: a meta-analysis

... early relapse predicted a worse PRS in recurrent osteosarco- ...to relapse either from the initial diagnosisor the ...to relapse might be used to recognize patients at higher risk for death after ...

9

Survival Analysis of Drug Abuse Relapse in Addiction Treatment Centers

Survival Analysis of Drug Abuse Relapse in Addiction Treatment Centers

... research. Relapse was defined as the subjects returned to even a single usage of a drug or more ...drug, relapse status and time of treatment to relapse (per ...

6

Factors associated with recurrence and survival length following relapse in patients with neuroblastoma

Factors associated with recurrence and survival length following relapse in patients with neuroblastoma

... CONCLUSION In conclusion, this study showed that the PROS for neuroblastoma patients has increased but long-term survival remains poor. Eighty percent of high-risk relapses occur within 2 years from diagnosis, in ...

10

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

... Although the longest period of follow-up did reach 16.75 years, there were only three patients who had follow-up data over 10 years. We have used OS rather than melanoma-related survival in the analyses, as ...

8

Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period

Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period

... Lambert–Eaton myasthenic syndrome (LEMS) is a paraneoplastic syndrome and only 3% of small cell lung carcinoma (SCLC) patients have LEMS. Moreover, the recurrence of SCLC after a disease-free survival (DFS) ...

5

Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344)

Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344)

... distinguish relapse from death within the domain of disease- free survival, which suggests that the secondary anatomic site codes may capture cancer ...

10

Relapse-free cure from multidrug-resistant tuberculosis in Germany.

Relapse-free cure from multidrug-resistant tuberculosis in Germany.

... Treatment failure is defined as a positive culture status six months after treatment initiation. 78[r] ...

12

Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry

Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry

... In addition, the lack of statistical significance in overall survival rate between patients with pattern I (diploidy) and pattern II hepatomas sug- gested that the prognosis of patients [r] ...

8

Challenges and methodologies in using progression free survival as a surrogate for overall survival In oncology

Challenges and methodologies in using progression free survival as a surrogate for overall survival In oncology

... progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line ...

24

Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer

Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer

... Dovepress surrogate markers for overall survival in advanced breast cancer considered minimal. Furthermore, in the present study, the relationship between PFS/TTP and OS was assessed using a trial-based approach. ...

10

Show all 10000 documents...

Related subjects